Jane Street Group LLC Has $164,000 Stock Position in Viemed Healthcare, Inc. (NASDAQ:VMD)

Jane Street Group LLC trimmed its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 75.6% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 22,356 shares of the company's stock after selling 69,320 shares during the quarter. Jane Street Group LLC owned 0.06% of Viemed Healthcare worth $164,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the stock. Perkins Coie Trust Co bought a new position in shares of Viemed Healthcare during the third quarter worth about $73,000. PDT Partners LLC acquired a new position in Viemed Healthcare during the 3rd quarter worth approximately $78,000. Victory Capital Management Inc. grew its stake in shares of Viemed Healthcare by 21.1% during the 2nd quarter. Victory Capital Management Inc. now owns 12,791 shares of the company's stock worth $84,000 after acquiring an additional 2,226 shares in the last quarter. Walleye Capital LLC acquired a new stake in shares of Viemed Healthcare in the third quarter valued at approximately $87,000. Finally, SG Americas Securities LLC bought a new stake in shares of Viemed Healthcare in the third quarter worth $89,000. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Viemed Healthcare

In other Viemed Healthcare news, Director Randy E. Dobbs sold 36,261 shares of the company's stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total value of $336,502.08. Following the transaction, the director now directly owns 107,706 shares in the company, valued at $999,511.68. The trade was a 25.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Nitin Kaushal sold 30,000 shares of Viemed Healthcare stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $9.56, for a total transaction of $286,800.00. Following the sale, the director now directly owns 126,843 shares of the company's stock, valued at $1,212,619.08. The trade was a 19.13 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 72,256 shares of company stock worth $674,739. Insiders own 20.00% of the company's stock.

Viemed Healthcare Stock Up 1.0 %

Viemed Healthcare stock traded up $0.08 during mid-day trading on Tuesday, reaching $8.00. The company's stock had a trading volume of 235,272 shares, compared to its average volume of 143,909. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. Viemed Healthcare, Inc. has a 12 month low of $6.21 and a 12 month high of $10.44. The business's 50 day simple moving average is $8.51 and its 200 day simple moving average is $7.90. The company has a market capitalization of $311.50 million, a price-to-earnings ratio of 29.63 and a beta of 1.47.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The firm had revenue of $58.00 million during the quarter.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.